Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Vinorelbine | hsa00010 | Glycolysis / Gluconeogenesis | 1.18E-02 | 2 | P60174, P06744 | TPI1, GPI | More | | Vinorelbine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Vinorelbine | hsa00053 | Ascorbate and aldarate metabolism | 1.80E-02 | 2 | P51648, Q9UEF7 | ALDH3A2, KL | More | | Vinorelbine | hsa00310 | Lysine degradation | 4.27E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Vinorelbine | hsa00500 | Starch and sucrose metabolism | 1.36E-03 | 3 | O43451, P35573, P06737 | MGAM, AGL, PYGL | More | | Vinorelbine | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Vinorelbine | hsa00561 | Glycerolipid metabolism | 4.36E-03 | 3 | O14494, P51648, P23743 | PLPP1, ALDH3A2, DGKA | More | | Vinorelbine | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Vinorelbine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Vinorelbine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.42E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Vinorelbine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Vinorelbine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Vinorelbine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Vinorelbine | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Vinorelbine | hsa01200 | Carbon metabolism | 1.99E-02 | 2 | P06744, P60174 | GPI, TPI1 | More | | Vinorelbine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.90E-02 | 3 | P17252, P10415, Q9NRA1 | PRKCA, BCL2, PDGFC | More | | Vinorelbine | hsa01524 | Platinum drug resistance | 6.12E-03 | 6 | Q13315, P10415, Q13489, P78417, P43246, P52701 | ATM, BCL2, BIRC3, GSTO1, MSH2, MSH6 | More | | Vinorelbine | hsa03040 | Spliceosome | 1.45E-04 | 11 | Q14562, O43143, O60508, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142 | DHX8, DHX15, CDC40, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8 | More | | Vinorelbine | hsa04020 | Calcium signaling pathway | 9.02E-04 | 8 | P21796, Q16566, P17252, P30679, P25116, P0DP23, P23634, Q9NRA1 | VDAC1, CAMK4, PRKCA, GNA15, F2R, CALM1, ATP2B4, PDGFC | More | | Vinorelbine | hsa04064 | NF-kappa B signaling pathway | 3.04E-03 | 8 | P10415, Q13489, P25963, P51617, Q13546, Q9UDY8, Q13315, O75293 | BCL2, BIRC3, NFKBIA, IRAK1, RIPK1, MALT1, ATM, GADD45B | More | | Vinorelbine | hsa04071 | Sphingolipid signaling pathway | 1.10E-03 | 7 | P17252, P21453, Q9H228, P01375, P10415, Q9UQC2, P01042 | PRKCA, S1PR1, EDG8, TNF, BCL2, GAB2, KNG1 | More | | Vinorelbine | hsa04072 | Phospholipase D signaling pathway | 1.06E-02 | 5 | P25116, P17252, O14494, P23743, Q9NRA1 | F2R, PRKCA, PLPP1, DGKA, PDGFC | More | | Vinorelbine | hsa04114 | Oocyte meiosis | 2.05E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Vinorelbine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Vinorelbine | hsa04141 | Protein processing in endoplasmic reticulum | 2.77E-02 | 5 | P27824, P30101, P60604, P11142, P08238 | CANX, PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | | Vinorelbine | hsa04145 | Phagosome | 2.46E-03 | 6 | Q15080, P14598, Q13509, P68371, Q13488, P27824 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, CANX | More | | Vinorelbine | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Vinorelbine | hsa04217 | Necroptosis | 3.16E-06 | 12 | P01375, P01568, P48023, Q13489, Q13546, P42224, Q14765, P08238, Q6FI13, Q99878, P10415, O43633 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, BCL2, CHMP2A | More | | Vinorelbine | hsa04310 | Wnt signaling pathway | 5.60E-03 | 3 | P30279, Q13485, O43318 | CCND2, SMAD4, MAP3K7 | More | | Vinorelbine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Vinorelbine | hsa04370 | VEGF signaling pathway | 1.29E-02 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Vinorelbine | hsa04371 | Apelin signaling pathway | 1.12E-03 | 9 | P62873, P63218, P50151, Q13370, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Vinorelbine | hsa04520 | Adherens junction | 1.09E-03 | 5 | Q13485, O43318, P84022, O95863, Q15223 | SMAD4, MAP3K7, SMAD3, SNAI1, PVRL1 | More | | Vinorelbine | hsa04540 | Gap junction | 5.44E-03 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Vinorelbine | hsa04620 | Toll-like receptor signaling pathway | 7.24E-03 | 5 | P51617, Q13546, P01568, P42224, P25963 | IRAK1, RIPK1, IFNA21, STAT1, NFKBIA | More | | Vinorelbine | hsa04621 | NOD-like receptor signaling pathway | 4.54E-02 | 7 | P08238, P42224, P01568, P25963, Q13489, P10415, Q13546 | HSP90AB1, STAT1, IFNA21, NFKBIA, BIRC3, BCL2, RIPK1 | More | | Vinorelbine | hsa04623 | Cytosolic DNA-sensing pathway | 4.52E-05 | 3 | P01568, Q13546, P25963 | IFNA21, RIPK1, NFKBIA | More | | Vinorelbine | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Vinorelbine | hsa04659 | Th17 cell differentiation | 1.64E-02 | 5 | P19174, P84022, Q13485, P08238, P07766 | PLCG1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Vinorelbine | hsa04664 | Fc epsilon RI signaling pathway | 2.35E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | | Vinorelbine | hsa04666 | Fc gamma R-mediated phagocytosis | 2.81E-02 | 4 | P23528, O14494, P14598, P17252 | CFL1, PLPP1, NCF1, PRKCA | More | | Vinorelbine | hsa04710 | Circadian rhythm | 1.79E-02 | 1 | O15516 | CLOCK | More | | Vinorelbine | hsa04720 | Long-term potentiation | 2.05E-02 | 3 | P17252, Q16566, P0DP23 | PRKCA, CAMK4, CALM1 | More | | Vinorelbine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Vinorelbine | hsa04724 | Glutamatergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Vinorelbine | hsa04725 | Cholinergic synapse | 8.04E-03 | 4 | P17252, P62873, Q16566, P10415 | PRKCA, GNB1, CAMK4, BCL2 | More | | Vinorelbine | hsa04727 | GABAergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Vinorelbine | hsa04744 | Phototransduction | 8.61E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Vinorelbine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Vinorelbine | hsa04914 | Progesterone-mediated oocyte maturation | 2.66E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Vinorelbine | hsa04916 | Melanogenesis | 2.90E-02 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | | Vinorelbine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Vinorelbine | hsa04925 | Aldosterone synthesis and secretion | 3.91E-02 | 3 | P0DP23, P17252, Q16566 | CALM1, PRKCA, CAMK4 | More | | Vinorelbine | hsa04926 | Relaxin signaling pathway | 4.94E-02 | 2 | P63218, P30679 | GNG5, GNA15 | More | | Vinorelbine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Vinorelbine | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Vinorelbine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Vinorelbine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.22E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Vinorelbine | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Vinorelbine | hsa05017 | Spinocerebellar ataxia | 2.16E-02 | 2 | Q8TB72, P21796 | PUM2, VDAC1 | More | | Vinorelbine | hsa05032 | Morphine addiction | 4.43E-02 | 3 | P63218, P50151, P43250 | GNG5, GNG10, GRK6 | More | | Vinorelbine | hsa05132 | Salmonella infection | 1.58E-05 | 11 | P51617, P25963, P08238, Q9UJU2, Q13546, Q13489, P10415, O75369, Q13561, Q13509, P68371 | IRAK1, NFKBIA, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, FLNB, DCTN2, TUBB3, TUBB2C | More | | Vinorelbine | hsa05140 | Leishmaniasis | 4.05E-03 | 6 | P14598, P42224, P25963, P29350, P51617, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, IRAK1, NCF4 | More | | Vinorelbine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Vinorelbine | hsa05145 | Toxoplasmosis | 1.95E-02 | 6 | P51617, P25963, P10415, Q13489, P42224, P11142 | IRAK1, NFKBIA, BCL2, BIRC3, STAT1, HSPA8 | More | | Vinorelbine | hsa05152 | Tuberculosis | 6.22E-04 | 8 | Q13488, P0DP23, P42224, P25208, P10415, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, STAT1, NFYB, BCL2, IFNA21, MALT1, IRAK1 | More | | Vinorelbine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Vinorelbine | hsa05162 | Measles | 4.50E-03 | 8 | P51617, P01568, P25963, P42224, P14784, P10747, P11142, P10415 | IRAK1, IFNA21, NFKBIA, STAT1, IL2RB, CD28, HSPA8, BCL2 | More | | Vinorelbine | hsa05166 | Human T-cell leukemia virus 1 infection | 1.77E-02 | 8 | P27824, P30279, P21796, P84022, Q13485, P07766, Q92830, P06746 | CANX, CCND2, VDAC1, SMAD3, SMAD4, CD3E, KAT2A, POLB | More | | Vinorelbine | hsa05168 | Herpes simplex virus 1 infection | 5.65E-04 | 14 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P51617, Q13398, Q9NR11, P17097, P17038, Q03923, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, ZNF211, ZNF302, ZNF7, ZNF43, ZNF85, BCL2 | More | | Vinorelbine | hsa05170 | Human immunodeficiency virus 1 infection | 3.95E-05 | 11 | P62873, P0DP23, P17252, Q13546, P01568, P51617, P25963, Q13315, P23528, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, IFNA21, IRAK1, NFKBIA, ATM, CFL1, BCL2, AP1M2 | More | | Vinorelbine | hsa05200 | Pathways in cancer | 2.28E-06 | 29 | P04628, Q13751, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, P20585, P52701, P14923, P30279, P10415, Q13489, Q12778, P25116, P62873, P63218, P50151, Q14344, P78417, O75293, P0DP23, P01568, P14784, P01042 | WNT1, LAMB3, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, MSH6, JUP, CCND2, BCL2, BIRC3, FOXO1, F2R, GNB1, GNG5, GNG10, GNA13, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | | Vinorelbine | hsa05203 | Viral carcinogenesis | 1.90E-02 | 6 | P06746, Q92830, P07948, P30279, P29083, Q93079 | POLB, KAT2A, LYN, CCND2, GTF2E1, H2BC9 | More | | Vinorelbine | hsa05210 | Colorectal cancer | 4.94E-02 | 2 | Q13485, P52701 | SMAD4, MSH6 | More | | Vinorelbine | hsa05214 | Glioma | 2.90E-02 | 3 | P0DP23, Q16566, P17252 | CALM1, CAMK4, PRKCA | More | | Vinorelbine | hsa05215 | Prostate cancer | 6.15E-03 | 5 | P10415, Q9UJU2, Q12778, Q9NRA1, P08238 | BCL2, LEF1, FOXO1, PDGFC, HSP90AB1 | More | | Vinorelbine | hsa05231 | Choline metabolism in cancer | 5.44E-03 | 4 | Q9NRA1, P23743, O14494, P17252 | PDGFC, DGKA, PLPP1, PRKCA | More | | Vinorelbine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Vinorelbine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | |